| scholarly article | Q13442814 |
| P50 | author | Jiří Bártek | Q12025039 |
| Pascal Fender | Q56980554 | ||
| P2093 | author name string | Hui Song | |
| André Lieber | |||
| Hongjie Wang | |||
| Jonas Persson | |||
| Qinghua Feng | |||
| Ines Beyer | |||
| Robert Strauss | |||
| Roma Yumul | |||
| Ruan van Rensburg | |||
| ZongYi Li | |||
| P2860 | cites work | Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions | Q39551866 |
| Oncolytic adenovirus based on serotype 3. | Q39616158 | ||
| Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells | Q39628198 | ||
| Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity | Q39908130 | ||
| Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice | Q39923180 | ||
| A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropism. | Q40026203 | ||
| Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines | Q40437699 | ||
| Xenograft models for liver metastasis: Relationship between tumor morphology and adenovirus vector transduction | Q40560870 | ||
| Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. | Q40643877 | ||
| Abnormal desmoglein expression by squamous cell carcinoma cells | Q41152907 | ||
| Desmoglein II-derived glycopeptides in human epidermis | Q41259831 | ||
| Adenovirus dodecahedron, a new vector for human gene transfer | Q45075858 | ||
| Predictive modeling in cancer: where systems biology meets the stock market. | Q45116753 | ||
| Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer | Q53356196 | ||
| Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses. | Q53545862 | ||
| Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer | Q54711475 | ||
| De novo formation of desmosomes in cultured cells upon transfection of genes encoding specific desmosomal components | Q58438399 | ||
| Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape | Q24307684 | ||
| MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells | Q28243727 | ||
| Development and characterization of a recombinant Madin-Darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1) | Q28582391 | ||
| A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy | Q30959165 | ||
| Homo- and heterotypic cell contacts in malignant melanoma cells and desmoglein 2 as a novel solitary surface glycoprotein. | Q33284374 | ||
| Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer | Q33394061 | ||
| Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? | Q33755906 | ||
| Understanding resistance to EGFR inhibitors-impact on future treatment strategies | Q34088424 | ||
| Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma | Q34569664 | ||
| Controlled Extracellular Matrix Degradation in Breast Cancer Tumors Improves Therapy by Trastuzumab | Q34621713 | ||
| Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. | Q34781681 | ||
| Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines | Q35534067 | ||
| Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas | Q36869621 | ||
| Epithelial-mesenchymal transition and tumour invasion | Q36934031 | ||
| Toward a stem cell gene therapy for breast cancer | Q37209024 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| monoclonal antibody | Q422248 | ||
| P304 | page(s) | 7080-7090 | |
| P577 | publication date | 2011-10-11 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer | |
| P478 | volume | 71 |
| Q64377866 | 1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors |
| Q42333514 | 2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA. |
| Q36023115 | A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses. |
| Q35156188 | Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds |
| Q91808144 | Antibody Structure and Function: The Basis for Engineering Therapeutics |
| Q26852287 | Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells |
| Q98289833 | Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial |
| Q39246243 | Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancer. |
| Q37428089 | Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis |
| Q39358604 | Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugs |
| Q64104514 | CryoEM structure of adenovirus type 3 fibre with desmoglein 2 shows an unusual mode of receptor engagement |
| Q55467684 | Designer Oncolytic Adenovirus: Coming of Age. |
| Q35099880 | Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells |
| Q27013675 | Desmosome regulation and signaling in disease |
| Q36825407 | Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models |
| Q27318180 | Functional characterisation of the WW minimal domain for delivering therapeutic proteins by adenovirus dodecahedron |
| Q39047491 | Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro |
| Q58759854 | Human adenovirus type 17 from species D transduces endothelial cells and human CD46 is involved in cell entry |
| Q35076226 | Identification of reproducible gene expression signatures in lung adenocarcinoma. |
| Q41861892 | Improving drug uptake and penetration into tumors: current and forthcoming opportunities. |
| Q34204024 | Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies |
| Q36208218 | Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1. |
| Q47197354 | Junction opener protein increases nanoparticle accumulation in solid tumors |
| Q54948734 | Mapping of Adenovirus of serotype 3 fibre interaction to desmoglein 2 revealed a novel 'non-classical' mechanism of viral receptor engagement. |
| Q50998666 | Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors. |
| Q38318962 | Overcoming physical barriers in cancer therapy. |
| Q91857309 | Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin |
| Q35034232 | Penton-dodecahedral particles trigger opening of intercellular junctions and facilitate viral spread during adenovirus serotype 3 infection of epithelial cells. |
| Q35651085 | Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin |
| Q38821198 | Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers |
| Q33607808 | Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro |
| Q38125197 | Strategies to increase drug penetration in solid tumors |
| Q27679683 | Structural and Functional Studies on the Interaction of Adenovirus Fiber Knobs and Desmoglein 2 |
| Q64110778 | Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy |
| Q61797466 | Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency |
| Q46448172 | The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth |
| Q27674368 | The Structural Basis for the Integrity of Adenovirus Ad3 Dodecahedron |
| Q51846287 | Tumor Restrictions to Oncolytic Virus |
Search more.